stars 1 stars 2 stars 3

BioPhausia is a Swedish specialty pharma company. BioPhausia focuses on marketing and sales of own products, licensed products and parallel-imported products. The portfolio includes strong brands such as Novalucol, Citodon and Mollipect. BioPhausia AB (publ) has its registered office in Stockholm and is listed on the Nasdaq OMX Nordic Exchange, Small cap.

View Top Employees from BioPhausia AB
Website http://www.biophausia.se
Revenue $4.4 million
Employees 1 (1 on RocketReach)
Founded 1994
Address Blasieholmsgatan 2, Stockholm, Stockholm 111 48, SE
Phone (468) 407-6430
Technologies
Industry Pharmaceuticals, Drug Manufacturing & Research, Biotechnology, Science and Engineering, Healthcare, Medical, Health Care, Pharmaceutical
SIC SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies
NAICS NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies

BioPhausia AB Questions

The BioPhausia AB annual revenue was $4.4 million in 2023.

1 people are employed at BioPhausia AB.

BioPhausia AB is based in Stockholm, Stockholm.

The NAICS codes for BioPhausia AB are [325, 32541, 3254, 32].

The SIC codes for BioPhausia AB are [28, 2834, 283].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users